Ginkgo Bioworks Holdings (DNA) Income towards Parent Company (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) posted Income towards Parent Company of -$6.5 million for Q1 2026, up 91.92% on a QoQ basis from -$80.8 million in Q4 2025, and up 14.63% year-over-year from -$5.7 million in Q1 2025.

Ginkgo Bioworks Holdings (DNA) Income towards Parent Company (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$6.5 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 14.63% year-over-year to -$6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$228.3 million (up 41.27% YoY) and the FY2025 annual result came in at -$312.8 million, up 42.83% from the prior year.
  • Income towards Parent Company was -$6.5 million for Q1 2026 at Ginkgo Bioworks Holdings, up from -$80.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$6.5 million in Q1 2026 and bottomed at -$670.6 million in Q2 2022.
  • A 5-year average of -$222.5 million and a median of -$173.1 million in 2022 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 1131.22% — and 2025, when it soared 95.39%.
  • Ginkgo Bioworks Holdings' Income towards Parent Company stood at -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then jumped by 49.2% to -$107.5 million in 2024, then climbed by 24.91% to -$80.8 million in 2025, then jumped by 91.92% to -$6.5 million in 2026.
  • Business Quant data shows DNA's Income towards Parent Company at -$6.5 million in Q1 2026, -$80.8 million in Q4 2025, and -$80.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Ginkgo Bioworks Holdings 445.24 Mn 301.37 Mn 16.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.53 Mn
Dec 31, 2025 -80.75 Mn
Sep 30, 2025 -80.76 Mn
Jun 30, 2025 -60.30 Mn
Mar 31, 2025 -7.65 Mn
Dec 31, 2024 -107.53 Mn
Sep 30, 2024 -56.40 Mn
Jun 30, 2024 -217.18 Mn
Mar 31, 2024 -165.91 Mn
Dec 31, 2023 -211.69 Mn
Sep 30, 2023 -302.89 Mn
Jun 30, 2023 -173.32 Mn
Mar 31, 2023 -204.97 Mn
Dec 31, 2022 -173.08 Mn
Sep 30, 2022 -670.13 Mn
Jun 30, 2022 -670.57 Mn
Mar 31, 2022 -592.59 Mn
Dec 31, 2021 -1.60 Bn
Sep 30, 2021 -102.41 Mn
Jun 30, 2021 -54.46 Mn